These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 35543075)

  • 41. Low expression of long noncoding RNA CTC-297N7.9 predicts poor prognosis in patients with hepatocellular carcinoma.
    Zhu S; Huang X; Zhang K; Tan W; Lin Z; He Q; Chen Y; Shang C
    Cancer Med; 2019 Dec; 8(18):7679-7692. PubMed ID: 31674731
    [TBL] [Abstract][Full Text] [Related]  

  • 42. pERK/pAkt phenotyping in circulating tumor cells as a biomarker for sorafenib efficacy in patients with advanced hepatocellular carcinoma.
    Li J; Shi L; Zhang X; Sun B; Yang Y; Ge N; Liu H; Yang X; Chen L; Qian H; Wu M; Yin Z
    Oncotarget; 2016 Jan; 7(3):2646-59. PubMed ID: 26544731
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Diagnostic Performance of Circulating Tumor Cells for Predicting of Hepatocellular Carcinoma in Hepatitis C Virus-High Risk Patients: Role of Liquid Biopsy.
    El-Mezayen HA; El -Kassas M; El-Taweel FM; Metwally FM; Ghonaim NA; Zahran RF
    Asian Pac J Cancer Prev; 2022 Jul; 23(7):2541-2549. PubMed ID: 35901363
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Application of Serum Annexin A3 in Diagnosis, Outcome Prediction and Therapeutic Response Evaluation for Patients with Hepatocellular Carcinoma.
    Ma XL; Jiang M; Zhao Y; Wang BL; Shen MN; Zhou Y; Zhang CY; Sun YF; Chen JW; Hu B; Gong ZJ; Zhang X; Cao Y; Pan BS; Zhou J; Fan J; Yang XR; Guo W
    Ann Surg Oncol; 2018 Jun; 25(6):1686-1694. PubMed ID: 29626309
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Aptamer-Mediated Transparent-Biocompatible Nanostructured Surfaces for Hepotocellular Circulating Tumor Cells Enrichment.
    Wang S; Zhang C; Wang G; Cheng B; Wang Y; Chen F; Chen Y; Feng M; Xiong B
    Theranostics; 2016; 6(11):1877-86. PubMed ID: 27570557
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Biomarker discovery in hepatocellular carcinoma (HCC) for personalized treatment and enhanced prognosis.
    Yu B; Ma W
    Cytokine Growth Factor Rev; 2024 Oct; 79():29-38. PubMed ID: 39191624
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Radiomics and circulating tumor cells: personalized care in hepatocellular carcinoma?
    Hesketh RL; Zhu AX; Oklu R
    Diagn Interv Radiol; 2015; 21(1):78-84. PubMed ID: 25430530
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Postoperative circulating tumor cells: An early predictor of extrahepatic metastases in patients with hepatocellular carcinoma undergoing curative surgical resection.
    Sun YF; Wang PX; Cheng JW; Gong ZJ; Huang A; Zhou KQ; Hu B; Gao PT; Cao Y; Qiu SJ; Zhou J; Fan J; Guo W; Yang XR
    Cancer Cytopathol; 2020 Oct; 128(10):733-745. PubMed ID: 32501632
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Multiple "Omics" data-based biomarker screening for hepatocellular carcinoma diagnosis.
    Liu XN; Cui DN; Li YF; Liu YH; Liu G; Liu L
    World J Gastroenterol; 2019 Aug; 25(30):4199-4212. PubMed ID: 31435173
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Quantified postsurgical small cell size CTCs and EpCAM
    Wang L; Li Y; Xu J; Zhang A; Wang X; Tang R; Zhang X; Yin H; Liu M; Wang DD; Lin PP; Shen L; Dong J
    Cancer Lett; 2018 Jan; 412():99-107. PubMed ID: 29031565
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Circulating tumor cells in hepatocellular carcinoma: single-cell based analysis, preclinical models, and clinical applications.
    Zhang Q; Rong Y; Yi K; Huang L; Chen M; Wang F
    Theranostics; 2020; 10(26):12060-12071. PubMed ID: 33204329
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Circulating Tumor DNA Clinical Applications in Hepatocellular Carcinoma: Current Trends and Future Perspectives.
    Bardol T; Pageaux GP; Assenat E; Alix-Panabières C
    Clin Chem; 2024 Jan; 70(1):33-48. PubMed ID: 37962158
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Improved method increases sensitivity for circulating hepatocellular carcinoma cells.
    Liu HY; Qian HH; Zhang XF; Li J; Yang X; Sun B; Ma JY; Chen L; Yin ZF
    World J Gastroenterol; 2015 Mar; 21(10):2918-25. PubMed ID: 25780289
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The predictive values of serum dickkopf-1 and circulating tumor cells in evaluating the efficacy of transcatheter arterial chemoembolization treatment on hepatocellular carcinoma.
    Wu X; Yang C; Yu H; Cao F; Shan Y; Zhao W
    Medicine (Baltimore); 2019 Jul; 98(30):e16579. PubMed ID: 31348291
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A Fully Automated and Integrated Microfluidic System for Efficient CTC Detection and Its Application in Hepatocellular Carcinoma Screening and Prognosis.
    Wang J; Li Y; Wang R; Han C; Xu S; You T; Li Y; Xia J; Xu X; Wang D; Tang H; Yang C; Chen X; Peng Z
    ACS Appl Mater Interfaces; 2021 Jun; 13(25):30174-30186. PubMed ID: 34142547
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Detection of circulating tumour cells enables early recurrence prediction in hepatocellular carcinoma patients undergoing liver transplantation.
    Wang PX; Xu Y; Sun YF; Cheng JW; Zhou KQ; Wu SY; Hu B; Zhang ZF; Guo W; Cao Y; Huang XW; Zhou J; Fan J; Yang XR
    Liver Int; 2021 Mar; 41(3):562-573. PubMed ID: 33205544
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The clinical significance of CTC enrichment by GPC3-IML and its genetic analysis in hepatocellular carcinoma.
    Yi B; Wu T; Zhu N; Huang Y; Yang X; Yuan L; Wu Y; Liang X; Jiang X
    J Nanobiotechnology; 2021 Mar; 19(1):74. PubMed ID: 33726759
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Circulating Tumor Cells in Hepatocellular Carcinoma: A Comprehensive Review and Critical Appraisal.
    Espejo-Cruz ML; González-Rubio S; Zamora-Olaya J; Amado-Torres V; Alejandre R; Sánchez-Frías M; Ciria R; De la Mata M; Rodríguez-Perálvarez M; Ferrín G
    Int J Mol Sci; 2021 Dec; 22(23):. PubMed ID: 34884878
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Circulating tumor cells in hepatocellular carcinoma: detection techniques, clinical implications, and future perspectives.
    Zhang Y; Li J; Cao L; Xu W; Yin Z
    Semin Oncol; 2012 Aug; 39(4):449-60. PubMed ID: 22846862
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Circulating tumor cells in breast cancer: detection systems, molecular characterization, and future challenges.
    Lianidou ES; Markou A
    Clin Chem; 2011 Sep; 57(9):1242-55. PubMed ID: 21784769
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.